PTC THERAPEUTICS INC (PTCT:NASDAQ)
$72.69 -0.78 (-1.0617%)
Analysed PTC THERAPEUTICS INC (PTCT:NASDAQ) News Sources
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
30-07-2026
yahoo.com
PTC Therapeutics (PTCT) Beats Q2 Earnings and Revenue Estimates
30-07-2026
yahoo.com
PTC Therapeutics (PTCT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
31-07-2026
yahoo.com
PTC Therapeutics (PTCT) Loses 20.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
04-08-2026
yahoo.com
PTC Therapeutics (PTCT) Stock Fair Value Edges Higher After Analyst Target Increases
05-08-2026
yahoo.com
PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program
12-08-2026
yahoo.com
PTC takes a chance on Sangamo’s Fabry disease gene therapy
13-08-2026
biopharmadive.com
PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal
16-08-2026
marketbeat.com
Wells Fargo Sees Up to 52% Upside in 2 Stocks
17-08-2026
yahoo.com
PTC Therapeutics Announces New Sephience™ (sepiapterin) Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as well as Consistent Favorable Safety Profile
24-08-2026
yahoo.com
What is the current price of PTC THERAPEUTICS INC (PTCT:NASDAQ)?
The current price of PTC THERAPEUTICS INC (PTCT:NASDAQ) is $72.69.
PTC THERAPEUTICS INC (PTCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of PTC THERAPEUTICS INC (PTCT:NASDAQ) since the previous trading day is $-0.78.
PTC THERAPEUTICS INC (PTCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of PTC THERAPEUTICS INC (PTCT:NASDAQ) since the previous trading day is -1.0617%.
What is the most recent average sentiment score for PTC THERAPEUTICS INC (PTCT:NASDAQ)?
The most recent average sentiment score for PTC THERAPEUTICS INC (PTCT:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for PTC THERAPEUTICS INC (PTCT:NASDAQ)?
The most recent sentiment for PTC THERAPEUTICS INC (PTCT:NASDAQ) is .
SEC-8K** Filing Available For PTC THERAPEUTICS INC (PTCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.